Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-03-27
2007-03-27
Stockton, Laura L. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S359100
Reexamination Certificate
active
10438152
ABSTRACT:
The invention is directed to N-substituted tricyclic 3-AMINOPYRAZOLE derivatives, which are useful as inhibitors of platelet-derived growth factor receptor (PDGF-R) kinase, and methods for the preparation of said derivatives. The present invention is further directed to pharmaceutical compositions comprising the compounds of the present invention and to methods for treating conditions such as tumors and other cell proliferative disorders.
REFERENCES:
patent: 3928378 (1975-12-01), Bauer et al.
patent: 4140785 (1979-02-01), Hoffman et al.
patent: 4220776 (1980-09-01), Whitney et al.
patent: 4420476 (1983-12-01), Philip et al.
patent: 5409930 (1995-04-01), Spada et al.
patent: 5474765 (1995-12-01), Thorpe
patent: 5476851 (1995-12-01), Myers et al.
patent: 5476871 (1995-12-01), Griffith et al.
patent: 5563173 (1996-10-01), Yatsu et al.
patent: 5762918 (1998-06-01), Thorpe
patent: 5855866 (1999-01-01), Thorpe et al.
patent: 5932580 (1999-08-01), Levitzki et al.
patent: 6342219 (2002-01-01), Thorpe et al.
patent: 6451834 (2002-09-01), Arnold et al.
patent: 2002/0016625 (2002-02-01), Falotico et al.
patent: 0620489 (1994-10-01), None
patent: 06/98611 (1999-10-01), None
patent: 6092963 (1994-04-01), None
patent: 6100561 (1994-04-01), None
patent: 6022109 (1996-01-01), None
patent: 11158149 (1999-06-01), None
patent: WO 95/07893 (1995-03-01), None
patent: WO 96/32907 (1996-10-01), None
patent: WO 99/17769 (1999-04-01), None
patent: WO 99/54308 (1999-10-01), None
patent: WO 00/07996 (2000-02-01), None
patent: WO 99/17770 (2000-03-01), None
patent: WO 00/59901 (2000-10-01), None
patent: WO 01/79198 (2001-10-01), None
patent: WO 02/12242 (2002-02-01), None
Schenone et al., Farmaco (2000), 55(5), pp. 383-388.
Reeve, W. et al., “The Synthesis of Hydrastic Acid.”J. Amer. Chem. Soc. (1951), pp. 1371-1372, vol. 73.
Baddeley, G., et al., “Friedel-Crafts Acylation and Alkylation. A Comparision of Inter-and Intra-molecular processes.”J. Chem. Soc. 1956, pp. 4647-4653.
Cantrell, T. S., et al., “The 2-Thiapentalenyl Anion.”Tetrahedron Lett. (1967), pp. 4477-4480, No. 45, Pergamon Press Ltd.
MacDowelli, D. W. H., et al., The Use of 2,5-Dichlorothiophene in the Synthesis of 3,4-Disubstituted Thiophene,J. Org. Chem., (1967), vol. 32, pp. 1226-1229.
Hampel, W., et al., “Reactions with Diazoketones. XII. 3-Oxothionaphthene.”Zeitschrift fuer Chemie, (1970), p. 343, vol. 10, No. 9. (English Abstract included).
Schoen, J., et al., “Arylamides of 3-Hydroxy-Indene-2-Thionocarboxylic Acid.”Roczniki Chemii, (1971), pp. 73-77, vol. 45, No. 1. (English Abstract included.).
Muraro, G., et al., “Thieno (c) Cyclenones.”Sciences Chimiques, (1971), pp. 1362-1365, vol. 273, No. 20. English Abstract included.).
Akhrem, V.A. et al., “Reaction Of Some Aromatic Nitrile Oxides With Dimedone,” translation fromKhim. Geterotsiki. Seodin., (1974), pp. 784-787, No. 7.
Torii, S., et al., “Electrochemical Acetoxylation of N-Acetylindolines and N-Acetylindoles. A New Synthesis of Indigos.”J. Org. Chem., (1978), pp. 2882-2885, vol. 43, No. 14.
Suebe, S. et al., “Synthesis Of Heterocyclic Chemistry.”J. Heterocyclic Chem., (1978), pp. 343-346, vol. 15, No. 2. (English Abstract included.).
Augustin, M., et al., “Synthesis and Reactions of Carbocyclic Acylketene-S, S-Acetals.”J. Fuer Praktische Chemie(Leipzig), (1979), pp. 215-225, vol. 321, No. 2. (English Abstract included.).
Augustin, M., et al., “Synthesis and Reactions of 2-[bis (alkylthio) Methylidene] Indan-1-Diones.”J. Fuer Praktische Chemie(Leipzig), (1979), pp. 205-214, vol. 321, No. 2. (English Abstract included.).
Caldwell, J; “The Significance of Phase II (Conjugation) Reactions in Drug Disposition and Toxicity.”Life Science, (1979), vol. 24, pp. 571-578.
Sugasawa, T. et al., “Aminohaloborane in Organic Synthesis.2.1Simple Synthesis of Indoles and 1-Acyl-3-indolinones Using Specific Ortho -Chloroacetylation of Anilines2.”J. Org. Chem., (1979), pp. 578-586, vol. 44, No. 4.
Gehrig, K., et al. “ortho-Cyano-1-arylazonaphthalenes and 3-Amino-2-arylbenzo[g]Indazoles from Cyclopalladated 1-Arylazonaphthalenes.”Helvetica Chimica Acta. (1983), pp. 2603-2606, vol. 66, Fasc. 8, No. 260.
Ranise, A., et al., “Derivatives of 4,5,6,7-Tetrahydro-7,8,8-Trimethyl-3-Phenylamino-4,7-Methano-2H-Indazole with Hypoglycemic and Hypotensive Activities.”Farmaco-Ed. Sc., (1983), pp. 101-111, vol. 38, Fasc. 2.
Maillard, J., et al., “Synthesis of Amino Derivatives of 4,5,6,7-Tetrahydrobenzothiazole. I. The 4-, 5-, 6- and 7-amino and N-Methylamino Derivatives With Central Dopaminergic Activity.”European J. Medicinal Chem. (1984), pp. 451-456, vol. 19, No. 5. (English Abstract Included.).
Ranise, A., et al., “Reactions of Camphor Pyrrolldinoenamine and its N-Phenyl 3-Carbothioamide with Sulphur and Nitrogen Reagents.”J. Chem. Research, (1984), pp. 42-43.
Ranise, A. et al., “Derivatives of 4,5,6,7-Tetrahydro-7,8,8-Trimethyl-3-Phenylamino-4-7-Methano-2H-Indazole With Hypotensive And Hypoglycemic Activities.” II Farmaco—Ed. Sc., (1984), pp. 200-207, vol. 39, Fasc. 3.
Thorpe, P.E., “Antibody Carriers Of Cytotoxic Agents In Cancer Thereapy:A Review.”Monoclonal Antibodies '84: Biological and Clinical Applications, (1984), pp. 475-506.
Arnon, R., “Monoclonal Antibodies For Immunotargeting of Drugs in Cancer Therapy,”Monoclonal Antibodies and Cancer Therapy, (1985), pp. 243-256.
Suesse, M., et al., “Synthesis of Qulnazoline-4-Thione- and 1H-Indazole Derivatives.”J. Fuer Praktische Chemie(Leipzig), (1986), pp. 635-639, vol. 328, No. 4. (English Abstract Included.).
Capon, B., et al., “Reversible Carbon Protonation In The Hydrolysis Of Heterocyclic Enol Methyl Ethers.”Tetrahedron, (1987), pp. 69-76, vol. 43, No. 1.
Rhee, G.S., et al., “Studies of Inositol Phospholipid-Specific Phospholipase C.”Science, (1989), pp. 546-550, vol. 244.
Hoye, T. R., et al., “Alkyne Insertion Reactions of Metal-Carbenes Derived from Enynyl α-Diazo Ketones [R'CN2COCR2CH2≡C(CH2)n−2CH=CH2],”American Chemical Society, (1990), pp. 4518-4520, 55.
Desphpande, A. R., et al., “Synthesis of 3-(3-Benzofuranyl)Coumarins,”Synthetic Communications, (1990), pp. 809-816, vol. 20, No. 6.
Villemin, D., et al., “A Convenient One-Pot Synthesis of Ketene Dithioacetals,”Synthesis, (1991), pp. 301-303, (4).
Majerus, P.W., et al., “Inositol Phosphate Biochemistry.”Annu. Rev. Biochem. (1992), pp. 225-250, vol. 61.
Saa, J. M., et al., “A Novel Entry to 4,7-Indoloquinones via the Fremy's Salt Oxidative Degradation of 4-Formyl-7-Hydroxyindoles,”J. Org. Chem., (1992), pp. 589-594, vol. 57.
Heldin, Carl-Henrik., “Structural And Functional Studies On Platelet-Derived Growth Factor,”Embo Journal, (1992), pp. 4251-4259, vol. 11, No. 12.
Passaniti, A., et al., “A Simply, Quantitative Method For Assessing Angiogenesis And Antiangiogenio Agents Using Reconstituted Basement Membrane, Heparin, and Fibroblast Growth Factor,”Laboratory Investigation, (1992), 519-528, vol. 67, No. 4.
Reimann, E., et al., “Intramolecular Alkylation of Aromatic Compounds, Part 32. Regioselective Synthesis of 4-Methyl-1-Pyrindan-5-One.”Pharmazie, (1995), pp. 589-592, vol. 50, No. 9. (English Abstract included).
Kasama, T., et al., “Interleukin-10 Expression and Chemokine Regulation During the Evolution of Murine Type II Collagen-included Arthritis.”Chemokines and Interleukin-10, (1995), pp. 2868-2876, vol. 95.
Mohamed, E.A., “Synthesis and biological activity of some 3-heterocyclyl-4-hydroxy-6-methyl-2 (1H)-quinolones.”Indian J. Chem., (1995), pp. 21-26, vol. 34B.
Wu, S-Q., et al., “Extensive amplification of bcr/abl fusion genes clustered on three marker chromosomes in human leukemic cell line K-562,ȁ
Brunmark Bengt Anders
Emanuel Stuart
Galemmo, Jr. Robert A.
Ho Chih Yung
Johnson Dana L.
Janssen Phamaceutica N.V.
Stockton Laura L.
LandOfFree
N-substituted tricyclic 3-aminopyrazoles as inhibitors for... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with N-substituted tricyclic 3-aminopyrazoles as inhibitors for..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and N-substituted tricyclic 3-aminopyrazoles as inhibitors for... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3737684